Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related deaths worldwide. Despite new technologies in diagnosis and treatment, the incidence and mortality of HCC continue rising. | Golgi phosphoprotein 3 GOLPH3 promotes hepatocellular carcinoma progression by activating mTOR signaling pathway